Can Implementation of Genetics and Pharmacogenomics Improve Treatment of Chronic Low Back Pain?

Can Implementation of Genetics and Pharmacogenomics Improve Treatment of Chronic Low Back Pain?

Etiology of back pain is multifactorial and not completely understood, and for the majority of people who suffer from chronic low back pain (cLBP), the precise cause cannot be determined. We know that back pain is somewhat heritable, chronic pain more so than acute. The aim of this review is to comp...

Full description

Bibliographic Details
Main Authors: Vladislav Suntsov, Filip Jovanovic, Emilija Knezevic, Kenneth D. Candido, Nebojsa Nick Knezevic
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Pharmaceutics
Subjects:
chronic low back pain (cLBP)
genetics
pharmacogenomics
personalized treatment
polymorphism
CYP450
Online Access:https://www.mdpi.com/1999-4923/12/9/894

Similar Items

Similar Items